All Terrain Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

All Terrain Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-908	Closed	-$88K	–	255
2018 Q4	$88K	Buy	+908	New	+$96.4K	0.04%	166
2018 Q3	–	Sell	-1,310	Closed	-$144K	–	248
2018 Q2	$144K	Hold	1,310	–	–	0.06%	177
2018 Q1	$140K	Hold	1,310	–	–	0.06%	174
2017 Q4	$140K	Buy	+1,310	New	+$140K	0.06%	187

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

All Terrain Financial Advisors's IBB Position: Q1 2019 in Review

All Terrain Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 908 shares — an estimated $88K sold.

All Terrain Financial Advisors first reported a position in IBB in Q4 2017 and held it in 4 quarters. The position peaked at $144K in Q2 2018. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

All Terrain Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
All Terrain Financial Advisors sold 908 iShares Biotechnology ETF shares in Q1 2019, an estimated $88K.
All Terrain Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 4 quarters.
All Terrain Financial Advisors's iShares Biotechnology ETF position peaked at $144K in Q2 2018.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on All Terrain Financial Advisors's 13F filing for Q1 2019, filed 14 May 2019.